Marex Group’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.47M Buy
5,784
+1,953
+51% +$455K 0.01% 423
2026
Q1
$936K Buy
+3,831
New +$892K 0.01% 453
2025
Q3
Sell
-4,151
Closed -$634K 931
2025
Q2
$634K Sell
4,151
-98,093
-96% -$15.1M 0.01% 351
2025
Q1
$17M Sell
102,244
-27,263
-21% -$4.27M 0.32% 58
2024
Q4
$18.7M Buy
129,507
+25,256
+24% +$3.91M 0.32% 57
2024
Q3
$16.9M Buy
104,251
+98,649
+1,761% +$15.7M 0.39% 56
2024
Q2
$819K Buy
5,602
+496
+10% +$73.8K 0.02% 243
2024
Q1
$808K Sell
5,106
-4,755
-48% -$757K 0.03% 198
2023
Q4
$1.55M Buy
+9,861
New +$1.51M 0.06% 178
2023
Q2
Sell
-1,813
Closed -$281K 270
2023
Q1
$281K Buy
+1,813
New +$293K 0.04% 206

Other funds holding JNJ

Marex Group's JNJ Position: Q2 2026 in Review

Marex Group increased its Johnson & Johnson (JNJ) stake by 51% in Q2 2026, buying an estimated $455K and bringing the position to 5,784 shares worth $1.47M. The position accounts for 0.01% of the portfolio, ranked #423.

Marex Group first reported a position in JNJ in Q1 2023 and has held it in 10 quarters since. The position peaked at $18.7M in Q4 2024. 4,677 funds tracked by Wall St. Rank hold JNJ as of Q2 2026.

  • Marex Group held 5,784 shares of Johnson & Johnson worth $1.47M as of Q2 2026.
  • Marex Group bought 1,953 Johnson & Johnson shares in Q2 2026, an estimated $455K.
  • Johnson & Johnson made up 0.01% of Marex Group's portfolio in Q2 2026, its #423 holding.
  • Marex Group first reported a position in Johnson & Johnson in Q1 2023 and has held it in 10 quarters since.
  • Marex Group's Johnson & Johnson position peaked at $18.7M in Q4 2024.
  • 4,677 funds tracked by Wall St. Rank held Johnson & Johnson as of Q2 2026.

Based on Marex Group's 13F filing for Q2 2026, filed 14 Aug 2026.